期刊文献+

高龄冠心病患者药物支架植入术后双联抗血小板治疗的出血并发症分析 被引量:13

Effects of Age on Bleeding Events in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy Following Drug Eluting Stent Implantation
下载PDF
导出
摘要 目的 评价年龄对冠心病药患者物支架植入术后双重抗血小板治疗的出血影响.方法 将575例因急性冠脉综合征植入药物支架进行双重抗血小板治疗(阿司匹林+氯比格雷)的患者,分成高龄组(70岁及以上,共224例)及低龄组(70岁以下,共351例),随访6~54个月,比较两组出血发生率、出血相关死亡的发生情况.结果 高龄组与低龄组中出血事件包括消化道出血11例 vs 6例,血尿9例 vs 6例,脑出血1例 vs 2例,因出血死亡2例 vs 1例.高龄组消化道出血更常见(P<0.05).两组手术住院期间出血事件均占整个出血事件的大多数(18/21 vs 11/14),未发生严重出血.院外出血3例(2例 vs 1例),均死亡.结论 冠心病植入药物支架后双重抗血小板治疗在高龄患者中出血并发症较多见,大多发生在住院期间.定期随访大便隐血可以及时发现轻微出血,避免病情进展;严重出血者预后不佳. Objective To evaluate effects of age on bleeding during dual antiplatelet therapy (DAPT) in coronary artery disease patients following drug eluting stent(DES) implantation. Methods In this obseational study,575 consecutive patients with coronary artery disease on DAPT after implanting DES were divided into two groups depending on age. Group A included 351 patients younger than 70 years, and group B included 224 patients older than 70 years. All patients were followed up for 6 to 54 months, and bleeding events were determined. Results There were 17 gastriointestinal bleeding events(6 patients in group A vs 11 patients in group B, P 〈 0.05 ), urine bleeding(6 patients in group A vs 9 patients in group B), hemorragic stroke(2 pa- tients in group A vs 1 patient in group B ), and death due to bleeding ( 1 patient in group A vs 2 patients in group B). Most bleeding events occurred during intervention operation hospitalization. Bleeding after discharge was associated worse prognosis. Conclusion Bleeding was more common in elderly patients on DAPT, and most of such events occurred during index hospitalization. Regular work- up of stool occult blood and urine blood may be necessary in elderly patients on DAPT.
出处 《血栓与止血学》 2013年第6期245-247,共3页 Chinese Journal of Thrombosis and Hemostasis
关键词 冠心病 经皮冠状动脉介入 双重抗血小板 出血 Coronary artery disease Percutaneous coronary intervention Dual antiplatelet Bleeding
  • 相关文献

参考文献6

  • 1LATIB A,CHA B, MORIC1 N,et al. Incidence of bleeding and com- pliance on prolonged dual antiplatelet therapy ( Aspirin + Thienopyri- dine) following drug- eluting stent Implantation [ J]. Am J Cardiol, 2008,102 : 1477-1481.
  • 2MUSUMECI G, ROSSINI L, LETFIERI C et al. Prognostic implica- tions of early and hmg- term bleeding events in patients on one- year dual antiplatelet therapy following drug-elutlng stent implantation [ J ]. Catheterization and Cardiovascular Interventions, 2012,80 : 395- 405.
  • 3BERGER PB, BHAT'I?D L, FUSTER V, et al. bleeding complications with dual antiplatelet therapy among patients with stable vascular dis- ease or risk factors for vascular disease [ J ]. Circulation, 2010,121 : 2575 -2583.
  • 4张道理,果春第,宁红霞,贾勤惠,马云娟.冠心病支架植入术后消化道出血的临床分析[J].中国医师杂志,2011,13(12):1646-1648. 被引量:3
  • 5ALLI O, SMITH C, HOFFMAN M, et al. Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel [ J ]. J Clin Gastroenterol, 2011, 45:410-414.
  • 6ARROYO R. C,POLO-TOMAS M, RONCALE'S M. P, et al. Lower GI bleeding is more common than upper among patients on dual anti- platelet therapy :long- term follow- up of a cohort of patients commonly using PPI co-therapy[ J]. Heart ,2012,98:718-723.

二级参考文献10

  • 1宋现涛,吕树铮,陈韵岱,苑飞,林运,田锐,陈欣,金泽宁,周渊,葛长江,孟康,柳弘.经皮冠状动脉介入治疗后患者住院期间合并上消化道出血分析[J].中华心血管病杂志,2007,35(4):308-311. 被引量:36
  • 2Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST- segment elevation. N Engl J Med,2005, 352(12) :1179-1189.
  • 3Nikolsky E, Stone GW, Kirtane A J, et al. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY ( Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Atn Coil Cardiol.2009,54 ( 14 ) : 1293-1302.
  • 4Moukarbel GV, Signorovitch JE, Pfeffer MA, et al. Gastrointestinal bleeding in high risk survivors of myocardial infarction : the VALIANT Trial. Eur Heart J,2009,30 ( 18 ) :2226-2232.
  • 5Ko DT, Yun L, Wijeysundera HC, et al. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years. Circ Cardiovasc lnterv,2010,3 (2) : 140-147.
  • 6Rerger JS, Bhatt DL, Steg PG,et al. Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J,2011,162 ( 1 ) :98- 105.
  • 7Berger PB, Bhatt DL,Fuster V,et al. CHARISMA Investigators. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation ,2010,121 ( 23 ) :2575-2583.
  • 8Doyle BJ, Rihal CS, Gastineau DA, et al. Bleeding, blood transfusion, and increased mortality after percutaneous coronary interven- tion: implications for contemporary practice. J Am Coil Cardiol, 2009,53 (22) :2019-2027.
  • 9Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use : a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coil Cardiol, 2008,52 ( 18 ) : 1502-1517.
  • 10Barkun AN, Bardou M, Kuipers EJ, et al. International Consensus Upper Gastrointestinal Bleeding Conference Group. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med, 2010,152(2) :101-113.

共引文献2

同被引文献80

引证文献13

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部